2022 annual financial data
Castle Biosciences 2022 Net margin
Direct answer
Net margin was -48.99%.
Operating income was -72,855,000 USD and net income was -67,138,000 USD.
Operating cash flow was -41,655,000 USD.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 137,039,000 USD
- Operating income
- -72,855,000 USD
- Net income
- -67,138,000 USD
- Operating cash flow
- -41,655,000 USD